{
    "organizations": [],
    "uuid": "79e3d01cf70b53a2269f6e6081da0a73e38c5dcb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-amgen-receives-european-commission/brief-amgen-receives-european-commission-approval-for-repatha-idUSFWN1SN0OZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Amgen Receives European Commission Approval For Repatha (Evolocumab)",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) - Amgen Inc:\n* AMGEN RECEIVES EUROPEAN COMMISSION APPROVAL FOR REPATHAÂ® (EVOLOCUMAB) TO PREVENT HEART ATTACK AND STROKE IN ADULTS WITH ESTABLISHED CARDIOVASCULAR DISEASE\n* AMGEN INC - EC APPROVED A NEW INDICATION IN REPATHA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-16T21:11:00.000+03:00",
    "crawled": "2018-05-17T14:41:35.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "amgen",
        "inc",
        "amgen",
        "receives",
        "european",
        "commission",
        "approval",
        "evolocumab",
        "prevent",
        "heart",
        "attack",
        "stroke",
        "adult",
        "established",
        "cardiovascular",
        "disease",
        "amgen",
        "inc",
        "ec",
        "approved",
        "new",
        "indication",
        "repatha",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}